Data / Form D filings / Neoantigenics, Inc.
Neoantigenics, Inc.: Form D filings
Neoantigenics, Inc., a biotechnology company in Charlottesville, VA, filed 2 Form D notices with the SEC between 2013 and 2015. The latest, on February 24, 2015, reports $3 million sold of a $3 million offering to 4 investors.
Find out what Neoantigenics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1000 Research Park Blvd., Suite 103, Charlottesville, VA, 22911
- Phone
- (434) 984-9723
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1589704
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 24, 2015 | New notice | $3,025,713 | $3,025,713 | $0 | 4 | Feb 12, 2015 | sec.gov |
| Oct 22, 2013 | New notice | $1,100,000 | $112,200 | $987,800 | 5 | Oct 21, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward J. Leary | Executive Officer, Promoter | |
| Brian A. Pollok | Executive Officer, Director, Promoter | |
| John C. Herr | Executive Officer, Director, Promoter | |
| Fred J. Eshelman | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Feb 23, 2015 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Neoantigenics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.